Cargando…
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)
BACKGROUND: Until now, various types of combined therapy with nucleotide analogs and pegylated interferon (Peg-INF) in patients with hepatitis B patients have been tried. However, studies regarding the benefits of de novo combination, late-add on, and sequential treatment are very limited. The objec...
Autores principales: | Jun, Dae Won, Ahn, Sang Bong, Kim, Tae Yeob, Sohn, Joo Hyun, Kim, Sang Gyune, Lee, Se Whan, Kim, Byung Ho, Kim, Dong Joon, Kim, Ja Kyung, Kim, Hyoung Su, Hwang, Seong Gyu, Choi, Won Choong, Tak, Won Young, Lee, Heon Ju, Yoon, Ki Tae, Yun, Byung Cheol, Lee, Sung Wook, Baik, Soon Koo, Park, Seung Ha, Park, Ji Won, Park, Sol Ji, Lee, Ji Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048918/ https://www.ncbi.nlm.nih.gov/pubmed/29998882 http://dx.doi.org/10.4103/0366-6999.235880 |
Ejemplares similares
-
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
por: Lim, Jae Hee, et al.
Publicado: (2011) -
A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
por: You, Byung Chul, et al.
Publicado: (2012) -
The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients
por: Jung, Hee Jae, et al.
Publicado: (2014) -
Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C
por: Choi, Jong Wook, et al.
Publicado: (2016) -
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study
por: Chon, Young Eun, et al.
Publicado: (2016)